- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genelux Corp (GNLX)
Genelux Corp stock price live, this page displays NASDAQ GNLX stock exchange data. View the GNLX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genelux Corp real time stock price chart below.
What Is the Genelux Corp Stock Price Today?
The Genelux Corp stock price today is 3.340.
What Is the Stock Symbol for Genelux Corp?
The stock symbol for Genelux Corp is ""GNLX.""
What Stock Exchange Does Genelux Corp Trade On?
Genelux Corp is listed and trades on the NASDAQ stock exchange.
Is Genelux Corp a Good Stock to Buy?
Determining whether Genelux Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNLX quote. (ISIN: US36870H1032)
What Is the Genelux Corp Stock Price Today?
The Genelux Corp stock price today is 3.340.
What Is the Stock Symbol for Genelux Corp?
The stock symbol for Genelux Corp is ""GNLX.""
What Stock Exchange Does Genelux Corp Trade On?
Genelux Corp is listed and trades on the NASDAQ stock exchange.
Is Genelux Corp a Good Stock to Buy?
Determining whether Genelux Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNLX quote. (ISIN: US36870H1032)
NASDAQ
Currency in USD
3.340
-0.250(-6.96%)
Closed·
After Hours
3.570+0.230(+6.89%)
·
Fair Value
An estimate of a Genelux's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.310
3.610
52 wk Range
1.930
5.885
GNLX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Post-Market activity
1/3
Fair Value
An estimate of a Genelux's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.3103.610
52 wk Range
1.9305.885
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GNLX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Genelux's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
18.000
Upside
+438.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Genelux receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Genelux receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Genelux receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Genelux Corp Company Profile
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and peritoneal mesothelioma. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Compare GNLX to Peers and Sector
Metrics to compare | GNLX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGNLXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.2x | −3.1x | −0.5x | |
PEG Ratio | −0.45 | 0.01 | 0.00 | |
Price/Book | 4.2x | 2.7x | 2.6x | |
Price / LTM Sales | - | 241.2x | 3.3x | |
Upside (Analyst Target) | 343.8% | 106.0% | 43.4% | |
Fair Value Upside | Unlock | 3.3% | 7.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.000
(+438.92% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-0.20 / -0.22
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Genelux Trade On?
Genelux is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Genelux?
The stock symbol for Genelux is "GNLX."
What Is the Genelux Market Cap?
As of today, Genelux market cap is 124.67M.
What Is Genelux's Earnings Per Share (TTM)?
The Genelux EPS (TTM) is -0.88.
When Is the Next Genelux Earnings Date?
Genelux will release its next earnings report on 18 Aug 2025.
From a Technical Analysis Perspective, Is GNLX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Genelux Stock Split?
Genelux has split 0 times.
How Many Employees Does Genelux Have?
Genelux has 24 employees.
What is the current trading status of Genelux (GNLX)?
As of 08 Aug 2025, Genelux (GNLX) is trading at a price of 3.34, with a previous close of 3.34. The stock has fluctuated within a day range of 3.31 to 3.61, while its 52-week range spans from 1.93 to 5.89.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.